|
|
Article: HBIO Reports First Quarter Results.
- Article from:
- Business Wire
- Article date:
- May 5, 2005
CopyrightCOPYRIGHT 2005 Business Wire. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
HOLLISTON, Mass. -- Harvard Bioscience, Inc. (Nasdaq: HBIO), today reported financial highlights for the three months ended March 31, 2005.
Revenues for the three months ended March 31, 2005 were $22.4 million, an increase of 1% over revenues of $22.2 million for the three months ended March 31, 2004. Net income, as measured under U.S. generally accepted accounting principles ("GAAP"), for the quarter ended March 31, 2005 was $0.2 million or $0.01 per basic and diluted share, compared to a net loss of $51,000, or $0.00 per basic and diluted share, for the quarter ended March 31, 2004. Non-GAAP adjusted net income was $0.8 million and $0.03 per diluted share for ...